Skip to main content

Lupus (Systemic Lupus Erythematosus) and cannabis in North Carolina

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
CBD oil with ≤0.9% THC,…
POSSESSION
$0/yr
STATE FEE
14–60 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

North Carolina statute and program

The North Carolina Epilepsy Alternative Treatment Act (CBD oil only) is the operating authority for North Carolina patient certification. The authoritative legal text is: N.C. Gen. Stat. § 90-94.1: Epilepsy Alternative Treatment Act.

What the evidence says about cannabis and Lupus (Systemic Lupus Erythematosus)

Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disease in which the immune system produces autoantibodies that attack the body's own tissues. Inflammation can affect joints, skin, kidneys, blood, lungs, heart, and the nervous system. Lupus is a relapsing-remitting disease — patients experience flares and periods of relative quiescence.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Lupus (Systemic Lupus Erythematosus) page.

How to qualify in North Carolina

The North Carolina Epilepsy Alternative Treatment Act (CBD oil only) requires the following registration steps for a Lupus (Systemic Lupus Erythematosus) patient (or any qualifying diagnosis):

  1. Get a neurologist’s written statement under the Epilepsy Alternative Treatment Act. A North Carolina-licensed neurologist must provide a written statement under N.C.G.S. §90-94.1 confirming that the patient has intractable epilepsy and may benefit from "hemp extract" (cannabis oil containing not more than 0.9% THC and at least 5% CBD by weight). The statute applies only to intractable epilepsy — North Carolina does not operate a general medical cannabis program.
  2. Register with the North Carolina Department of Health and Human Services. The patient or the patient’s legal guardian registers with the North Carolina Department of Health and Human Services using the neurologist’s written statement, a North Carolina driver license or state ID, and proof of residency. There is no separate online portal; registration is handled by mail or in person at NC DHHS.
  3. No state registration fee. North Carolina does not charge a patient registration fee under §90-94.1. There is also no dispensary infrastructure: the statute authorizes "registered caregivers" — typically a parent of a child with intractable epilepsy — to possess and administer hemp extract obtained out of state. The Cherokee Indian Hospital (on Eastern Band of Cherokee Indians sovereign land in Cherokee, NC) operates the only in-state medical cannabis dispensary, available to registered tribal members only.
  4. Obtain hemp extract from out of state or the EBCI dispensary. Registered patients may possess hemp extract obtained from out-of-state cannabis programs (most commonly Colorado, Virginia, or Washington). The Eastern Band of Cherokee Indians’ Qualla Enterprises tribal dispensary in Cherokee, NC operates a tribal medical cannabis program for enrolled members. North Carolina does not honor out-of-state medical cards for general use, but registered hemp-extract patients have an affirmative defense under §90-94.1 against possession charges.
State registration fee
$0
Physician visit (typical)
$200–$400
Certification to card
14–60 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full North Carolina registration steps, fees, and reciprocity rules, see the North Carolina cannabis-laws page.

ICD-10 code

A certifying physician documenting Lupus (Systemic Lupus Erythematosus) for the North Carolina medical cannabis program will typically record ICD-10 M32.9 or SNOMED-CT 55464009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does North Carolina list Lupus (Systemic Lupus Erythematosus) as a qualifying condition for medical cannabis?

No. North Carolina's qualifying-condition list does not currently include Lupus (Systemic Lupus Erythematosus), and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Lupus (Systemic Lupus Erythematosus) in North Carolina have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. North Carolina program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a North Carolina medical marijuana card for Lupus (Systemic Lupus Erythematosus)?

Because North Carolina does not currently list Lupus (Systemic Lupus Erythematosus) as a qualifying condition, a card for Lupus (Systemic Lupus Erythematosus) alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in North Carolina who is registered with North Carolina Epilepsy Alternative Treatment Act (CBD oil only) and willing to evaluate Lupus (Systemic Lupus Erythematosus) cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. North Carolina does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Lupus (Systemic Lupus Erythematosus)?

For Lupus (Systemic Lupus Erythematosus), evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Lupus (Systemic Lupus Erythematosus) lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Lupus (Systemic Lupus Erythematosus) should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Lupus (Systemic Lupus Erythematosus) and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Lupus (Systemic Lupus Erythematosus); the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. N.C. Gen. Stat. § 90-94.1: Epilepsy Alternative Treatment Actaccessed May 15, 2026
  2. NORML: North Carolina Lawsaccessed May 15, 2026
  3. Wikipedia: Cannabis in North Carolinaaccessed May 15, 2026
  4. N.C. Gen. Stat. §90-95: Violations; penalties (controlled substances)accessed May 17, 2026
  5. Eastern Band of Cherokee Indians (EBCI) — Great Smoky Cannabis Co. (Qualla Boundary tribal dispensary)accessed May 17, 2026
  6. North Carolina Department of Agriculture: Industrial Hemp Programaccessed May 17, 2026
  7. North Carolina General Assembly bill trackeraccessed May 17, 2026
  8. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases: Lupusaccessed May 18, 2026
  9. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 18, 2026

    “Substantial evidence that cannabis or cannabinoids are effective for chronic pain in adults.”

  10. Lupus Foundation of America: Marijuana and Lupusaccessed May 18, 2026
  11. American College of Rheumatology: 2023 Guideline for SLE Management (executive summary)accessed May 18, 2026
  12. MedlinePlus: Systemic lupus erythematosusaccessed May 18, 2026